We are live on
!
Find out more
AA
AlphaCentric Advisors Portfolio holdings
AUM
$100M
This Fund
S&P 500
This Quarter
Est. Return
+5.45%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$180M
AUM Growth
+$35.3M
(+24%)
Cap. Flow
+$33.3M
Cap. Flow
% of AUM
18.49%
Top 10 Holdings %
Top 10 Hldgs %
21.58%
Holding
287
New
78
Increased
46
Reduced
73
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$4.54M |
| 2 |
Coherus Oncology
CHRS
|
+$3.29M |
| 3 |
Amylyx Pharmaceuticals
AMLX
|
+$2.71M |
| 4 |
Embecta
EMBC
|
+$2.55M |
| 5 |
Invesco S&P 500 Pure Value ETF
RPV
|
+$2.33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$4.1M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$2.81M |
| 3 |
Invesco NASDAQ 100 ETF
QQQM
|
+$2.81M |
| 4 |
Innoviva
INVA
|
+$2.07M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
+$1.63M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 59.9% |
| 2 | Real Estate | 10.66% |
| 3 | Financials | 4.01% |
| 4 | Technology | 3.46% |
| 5 | Consumer Discretionary | 2.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Invesco Senior Loan ETF
BKLN
$7.19B
| $410K | 0.23% |
19,486
-2,580
| -12% | -$53.8K |
|
102
State Street SPDR S&P International Dividend ETF
DWX
$525M
| $405K | 0.22% |
11,782
+3,285
| +39% | +$115K |
|
103
EQT Corp
EQT
$31B
| $384K | 0.21% |
9,328
+2,815
| +43% | +$99.5K |
|
104
D.R. Horton
DHI
$42.4B
| $365K | 0.2% |
3,000
| – | – |
|
105
United Airlines
UAL
$37.5B
| $365K | 0.2% |
6,645
+4,402
| +196% | +$208K |
|
106
Medtronic
MDT
$106B
| $352K | 0.2% |
4,000
| – | – |
|
|
RBOT
107
DELISTED
Vicarious Surgical
RBOT
| $320K | 0.18% |
5,833
| – | – |
|
108
ExxonMobil
XOM
$611B
| $290K | 0.16% |
2,704
-1,531
| -36% | -$167K |
|
|
SAFE
109
Safehold
SAFE
$1.22B
| $284K | 0.16% |
11,972
-1
| -0% | -$27 |
|
110
Delta Air Lines
DAL
$55.4B
| $281K | 0.16% |
+5,901
| New | +$218K |
|
|
CTRA
111
DELISTED
Coterra Energy
CTRA
| $279K | 0.15% |
11,020
-5,708
| -34% | -$142K |
|
112
Microbot Medical
MBOT
$118M
| $272K | 0.15% |
100,000
| – | – |
|
113
American Airlines Group
AAL
$9.91B
| $268K | 0.15% |
+14,911
| New | +$219K |
|
114
Progressive
PGR
$121B
| $259K | 0.14% |
1,953
-155
| -7% | -$20.8K |
|
115
Aflac
AFL
$63.5B
| $254K | 0.14% |
3,638
-267
| -7% | -$17.9K |
|
116
ConocoPhillips
COP
$140B
| $253K | 0.14% |
2,442
-1,669
| -41% | -$171K |
|
|
ASXC
117
DELISTED
Asensus Surgical, Inc.
ASXC
| $253K | 0.14% |
500,000
| – | – |
|
118
State Street SPDR Nuveen ICE High Yield Municipal Bond ETF
HYMB
$3.08B
| $248K | 0.14% |
9,900
-100
| -1% | -$2.49K |
|
119
PACCAR
PCAR
$66.4B
| $246K | 0.14% |
+2,942
| New | +$218K |
|
120
Marathon Petroleum
MPC
$91.3B
| $245K | 0.14% |
2,102
-2,507
| -54% | -$291K |
|
121
Pultegroup
PHM
$24B
| $244K | 0.14% |
+3,142
| New | +$213K |
|
122
Johnson & Johnson
JNJ
$609B
| $243K | 0.14% |
1,471
-106
| -7% | -$17.1K |
|
123
Genuine Parts
GPC
$17.2B
| $239K | 0.13% |
1,415
-95
| -6% | -$15.5K |
|
124
Lamb Weston
LW
$6.46B
| $238K | 0.13% |
+2,071
| New | +$231K |
|
125
McDonald's
MCD
$190B
| $238K | 0.13% |
+796
| New | +$231K |
|
Similar funds
WCM
FCM
BIA
AGAM
E
HCM
AC
OIS
AlphaCentric Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, AlphaCentric Advisors held 287 positions worth $180M, up 24% from $145M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
AlphaCentric Advisors deployed $33.3M of net new capital in Q2 2023, opening 78 new positions and adding to 46 existing holdings. Its largest new stake was Embecta: 93,500 shares worth $2.02M.
By sector, the portfolio is most concentrated in Healthcare at 60% of assets, up from 56% a quarter earlier, followed by Real Estate and Financials.
On the sell side, the largest reduction was iShares 1-3 Year Treasury Bond ETF, an estimated $4.1M trimmed.
- AlphaCentric Advisors's largest Q2 2023 buy was Embecta: 93,500 shares worth $2.02M.
- AlphaCentric Advisors added most to Jazz Pharmaceuticals in Q2 2023, an estimated $4.54M increase.
- AlphaCentric Advisors's biggest Q2 2023 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $4.1M.
- AlphaCentric Advisors fully exited Invesco QQQ Trust in Q2 2023, selling an estimated $2.81M.
- AlphaCentric Advisors's ten largest holdings make up 22% of its $180M portfolio in Q2 2023.
- AlphaCentric Advisors opened 78 new positions and closed 55 in Q2 2023.
- AlphaCentric Advisors's portfolio value rose 24% quarter-over-quarter to $180M.
Based on AlphaCentric Advisors's 13F filing for Q2 2023, filed 8 Aug 2023.